GlassScriptPhysician profile
Jason Lee Holt
NPI 1932328267
$1,780.43
in general payments reported to CMS, 2019-2025
13 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $487 · 2020: $284 · 2021: $282 · 2022: $341 · 2023: $257 · 2024: $130.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $387.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $386.56 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $647.54 | 2021-2024 | Intellis Adaptivestim, Vanta Adaptivestim, Synchromedii |
| Medtronic USA, INC. | $617.54 | 2019-2020 | |
| Boston Scientific Corporation | $117.89 | 2020-2023 | Wavewriter Alpha Prime 16 |
| Curonix LLC | $97.95 | 2024 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Collegium Pharmaceutical, INC. | $65.80 | 2019-2022 | |
| Midsouth Orthopedics INC. | $54.29 | 2019 | |
| Spr Therapeutics, INC | $40.30 | 2023 | Sprint Pns System |
| Vertos Medical, INC. | $33.27 | 2023 | Mild Device Kit |
| Nevro Corp. | $32.15 | 2021-2024 | Senza |
| Nalu Medical, INC. | $24.31 | 2022 | |
| Stimwave Technologies Incorporated | $21.28 | 2019 | |
| Pfizer INC. | $15.00 | 2019 | |
| Bioventus LLC | $13.11 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jason Holt listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.